Teduglutide Reference

Educational, not medical advice reference for Teduglutide: Hormonal, GI; regulatory status, evidence posture, source review, and schedule notes.…

Plain English

What it is
Teduglutide, sold as Gattex (and Revestive in some countries), is an FDA-approved prescription medicine. It is a lab-made copy of GLP-2, a natural gut hormone made in the intestine. It is a different hormone from the GLP-1 weight-loss drugs people hear about.
What people use it for
Doctors prescribe it for adults and children with short bowel syndrome, a condition where the gut cannot absorb enough nutrition so the person depends on IV (tube) feeding. It is a treatment for that gut problem, not a weight-loss product.
What the science shows
It is FDA-approved, which means human studies supported its use for short bowel syndrome. It works by acting on the same gut receptor as the body's own GLP-2 hormone. pepSmart shows only label-reference information for this medicine.
The catch
It carries real safety warnings on its label. It can speed up abnormal cell growth, so the label calls for a colon and upper-gut exam to find and remove polyps before treatment and again later. It has also been linked to fluid buildup (including heart failure in studies) and to gallbladder or bile-duct problems. It is a prescription medicine for a serious gut condition, not a fitness or fat-loss aid.

Reference summary

Teduglutide is a label-verified GLP-2 analog. pepSmart surfaces label-reference content only.

Regulatory and posture

Categories
Hormonal, GI
Aliases
Gattex, Revestive, GLP-2 analog
Evidence posture
human
Regulatory status
FDA-approved prescription medication (Gattex; Revestive in some markets). Indicated for short bowel syndrome in patients dependent on parenteral support. Not a weight-loss drug.
Content review status
label verified

Selected public sources

Related tools

For research and educational purposes only. Not medical advice.